Vnitr Lek 2020, 66(2):e48-e52 | DOI: 10.36290/vnl.2020.041

Inherited C2-complement deficiency: variable clinical manifestation (case reports and review)

Pavlína Králíčková1, Ctirad Andrýs1, Tomáš Freiberger2,3, Jan Krejsek1
1 Ústav klinické imunologie a alergologie LF UK a FN Hradec Králové
2 Centrum kardiovaskulární a transplantační chirurgie Brno
3 Ústav klinické imunologie a alergologie LF MU a FN u sv. Anny Brno

C2 deficiency represents the most frequent type of a complement deficiency. Clinical manifestation includes infections caused by encapsulated bacteria (Steptococcus pneumoniae, Neisseria meningitidis) such as meningitis, gonitis, pneumonia or septicaemia. A causative treatment has not been available yet. A prophylactic vaccination and/or a long-term antibiotics prophylaxis are recommended. Here we report 2 patients from 2 unrelated families. The first patient suffered from recurrent otitis in his childhood. He underwent osteomyelitis, meningitis complicates with hear-loss, and one episode of pneumonia during adulthood. The second index patient underwent uncomplicated meningitis in his preschool age. He has been treated for recurrent upper-airways infections later. His sister has been completely asymptomatic. The deletion 28 bp (c.841-849+19del28) in C2-gene was detected in all of them in homozygous form. Our paper highlights the variability of a clinical manifestation in homozygous carriers, ranged from asymptomatic cases to patients with history of severe complications. The diagnosis is frequently made even in adulthood.

Keywords: complement system, C2, immunodeficiency, meningitis, pneumococcal disease, vaccination.

Published: April 2, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Králíčková P, Andrýs C, Freiberger T, Krejsek J. Inherited C2-complement deficiency: variable clinical manifestation (case reports and review). Vnitr Lek. 2020;66(2):e48-52. doi: 10.36290/vnl.2020.041.
Download citation

References

  1. Krejsek J, Andrýs C. Komplementový systém. In: Krejsek J, Andrýs C. Krčmová I Imunologie člověka. 1. Vydání. Hradec Králové, nakladatelství Garamond s. r. o., 2016, 78-86.
  2. Ferenčík M, Rovenský J, Shoenfeld Y et al. Komplementový systém. In: Imunitní system - informace pro každého. 1. Vydání. Praha: Grada Publishing 2015: 48-51.
  3. Modell V, Gee B, Lewis DB, et al. Global study of primary immunodeficiency diseases (PI) - diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res 2011; 51: 61-70. Go to original source... Go to PubMed...
  4. Babovic-Vuksanovic D, Snow K, Ten RM. Mannose-binding lectin (MBL) deficiency. Variant alleles in a midwestern population of the United States. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol 1999; 82: 134-138. Go to original source... Go to PubMed...
  5. Grumach AS, Kirschfink M. Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach. Mol Immunol 2014; 61: 110-117. Go to original source... Go to PubMed...
  6. Šrotová A, Litzman J, Rumlarová Š, et al. Recurrent meningitis and inherited complement deficiency. Epidemiol Mikrobiol Imunol 2016; 65: 238-242.
  7. Jönsson G, Truedsson L, Sturfelt G, et al. Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine (Baltimore) 2005; 84: 23-34. Go to original source... Go to PubMed...
  8. Turley AJ, Gathmann B, Bangs C, et al. Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe. J Clin Immunol 2015; 35: 199-205. Go to original source... Go to PubMed...
  9. Pickering MC, Botto M, Taylor PR, et al. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 2000; 76: 227-324. Go to original source... Go to PubMed...
  10. Agnello V Association of systemic lupus erythematosus and SLE-like syndromes with hereditary and acquired complement deficiency states. Arthritis Rheum 1978; 21: (Suppl. 5): 146-152.
  11. Jönsson G, Truedsson L, Sturfelt G, et al. Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine (Baltimore) 2005; 84: 23-34. Go to original source... Go to PubMed...
  12. Stegert M, Bock M, Trendelenburg M. Clinical presentation of human C1q deficiency: How much of a lupus? Mol Immunol 2015; 67: 3-11. Go to original source... Go to PubMed...
  13. Zhao W, Ding Y, Lu J, et al. Genetic analysis of complement pathway in C3 glomerulopathy. Nephrol Dial Transplant 2018 (doi: 10.1093/ndt/gfy033, ahead of print). Go to original source... Go to PubMed...
  14. Kaplan BS, Ruebner RL, Spinale JM, et al. Current treatment of atypical hemolytic uremic syndrome. Intractable Rare Dis Res 2014; 3: 34-45. Go to original source... Go to PubMed...
  15. Mauer M, Magert M, Ansotegui J, et al. The international WAO/EAACI guideline for the management of hereditary angioedema. The 2017 revision and update. Allergy 2018; doi10.1111/all.13384. Go to original source...
  16. Johnson CA, Densen P, Hurfold jr. RK et al. Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing. J Biol Chem 1992; 267: 9347-9353. Go to original source...
  17. Yu CY. Molecular genetics of the human MHC complement gene cluster. Exp Clin Immunogenet 1998; 15: 213-230. Go to original source... Go to PubMed...
  18. Litzman J, Freiberger T, Bartonková D, et al. Early manifestation and recognition of C2 complement deficiency in the form of pyogenic infection in infancy. J Paediatr Child Health 2003; 39: 274-277. Go to original source... Go to PubMed...
  19. Alper CA, Xu J, Cosmopoulos K, et al. Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency. J Clin Immunol 2003; 23: 297-305. Go to original source... Go to PubMed...
  20. Gaschignard J, Levy C, Chrabieh M. Invasive pneumococcal disease in children can reveal a primary immunodeficiency. Clin Infect Dis Off Publ Infect Dis Soc Am 2014; 59: 244-251. Go to original source... Go to PubMed...
  21. Attwood JT, Williams Y, Feighery C. Impaired IgG responses in a child with homozygous C2 deficiency and recurrent pneumococcal septicaemia. Acta Paediatr Oslo Nor 2001; 90: 99-101. Go to original source... Go to PubMed...
  22. Hussain A, Prasad KSRK, Bhattacharyya D, et al. C2 deficiency primary meningococcal arthritis of the elbow by Neisseria meningitidis serogroup Y in a 12-year old girl. Infection 2007; 35: 287-288. Go to original source... Go to PubMed...
  23. Lintner KE, Wu YL, Yang Y, et al. Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases. Front Immunol 2016; 7: 36. Go to original source... Go to PubMed...
  24. Brodszki N, Skattum L, Bai X, et al. Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies. Vaccine 2015; 33: 1839-1845. Go to original source... Go to PubMed...
  25. http://www.vakcinace.eu/aktuality/archiv-aktualit
  26. http://www.vakcinace.eu/doporuceni-a-stanoviska (Doporučení České vakcinologické společnosti ČLS JEP pro očkování proti invazivním meningokokovým onemocněním.)




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.